1.Hui, D.Y.,
and Harmony, J.A.K. (1979) Interaction of plasma lipoproteins with
erythrocytes. I. Alterations of human erythrocyte morphology.
Biochim.
Biophy. Acta
550, 407‑424.
2.Hui, D.Y.,
and Harmony, J.A.K. (1979) Interactions of plasma lipoproteins with
erythrocytes. II. Modulation of membrane-associated enzyme.
Biochim.
Biophys. Acta
550, 425‑434.
3.Hui, D.Y.,
Berebitsky, G.L., and Harmony, J.A.K. (1979) Mitogen‑induced calcium
ion accumulation by human lymphocytes: Influence of plasma
lipoproteins.
J. Biol.
Chem.
254, 4666‑4673.
4. Hui, D.Y., and Harmony, J.A.K. (1979) Erythrocyte
spectrin alteration induced by low density lipoprotein. In Normal
and Abnormal Red Cell Membranes.
(Lux, S.E., Marchesi, V.T., and Fox, C.F. eds.), Alan Liss Inc. pp.
413-423
5. Hui, D.Y., and Harmony, J.A.K. (1979) Low density
lipoprotein induced alteration of erythrocyte spectrin. J.
Supramol. Struc. 10, 253‑263.
6. Hui, D.Y. and Harmony, J.A.K. (1980) Inhibition by
low density lipoproteins of mitogen stimulated cyclic nucleotide
production by lymphocytes. J. Biol. Chem. 255, 1413‑1419.
7.Hui, D.Y.,
and Harmony, J.A.K. (1980) Phosphatidylinositol turnover in mitogen‑
activated lymphocytes: Suppression by low density lipoproteins.
Biochem.
J.
192, 91‑98.
8.Hui, D.Y.,
and Harmony, J.A.K. (1980) Inhibition of calcium accumulation by
mitogen activated lymphocytes: Role of membrane bound lipoproteins.
Proc.
Natl. Acad. Sci. USA 77,
4764‑4768.
9. Hui, D.Y., Harmony, J.A.K., Innerarity, T.L., and
Mahley, R.W.(1980) Immunoregulatory plasma lipoproteins: Role of
apoproteins E and B. J. Biol. Chem. 255, 11775‑11781.
10.
Hui, D.Y., Noel, J.G., and Harmony, J.A.K. (1981) Binding of
plasma lipoproteins to erythrocytes. Biochim. Biophys. Acta
664, 513‑526.
11.
Harmony, J.A.K., and Hui, D.Y. (1981) Inhibition by
membrane-bound LDL of the primary inductive events in mitogen
stimulated lymphocytes.
Cancer
Res.
41, 3799‑3802.
12.
Noel, J.G., Hui, D.Y., Blankership, D.T., and Harmony, J.A.K.
(1981) Reduced immunoregulatory potency of low density lipoproteins
with selectively modified arginine and lysine residues of
apolipoprotein E. Biochim. Biophys. Acta 665, 519‑530.
13.
Hui, D.Y., Innerarity, T.L., and Mahley, R.W. (1981)
Lipoprotein binding to canine hepatic membranes: Distinct apoprotein E
and apoprotein B,E receptors.
J. Biol. Chem. 256, 5646‑5665.
14.
Innerarity, T.L., Kempner, E.S., Hui, D.Y., and Mahley, R.W.
(1981) Functional unit of the low density lipoprotein receptor of
fibroblasts: A 100,000 dalton structure with multiple binding sites.
Proc. Natl. Acad. Sci. USA 78, 4378‑4382.
15.
Mahley, R.W., Hui, D.Y., Innerarity, T.L., and Weisgraber, K.H.
(1981) Two independent lipoprotein receptors on hepatic membranes of
dog, swine, and man: Apo‑B,E and Apo‑E receptors. J. Clin.
Invest. 68, 1197‑1206.
16.
Innerarity, T.L., Hui, D.Y., and Mahley, R.W. (1982) Hepatic
apoprotein E (remnant) receptors. In Lipoproteins and Coronary
Atherosclerosis. Elsevier/North Holland Biomedical Press,
Amsterdam, pp.173-181
17.
Hui, D.Y., Innerarity, T.L., and Mahley, R.W. (1984) Defective
hepatic lipoprotein receptor binding of a‑very low density
lipoproteins from type III hypercholesterolemic patients: Importance
of apolipoprotein E. J. Biol. Chem. 259, 860‑869.
18.
Funke, H., Boyles, J., Weisgraber, K.H., Ludwig, E.H., Hui, D.Y.,
and Mahley, R.W. (1984) Uptake of apoE-containing high density
lipoproteins by hepatic parenchymal cells.
Arteriosclerosis 4, 452‑461.
19.
Hui, D.Y., Innerarity, T.L., Milne, R.W., Marcel, Y.L., and
Mahley, R.W. (1984) Binding of chylomicron remnants and ‑very low
density lipoproteins to hepatic and extrahepatic lipoprotein
receptors: A process independent of apo-B48. J. Biol. Chem.
259, 15060‑15068.
20.
Vogel, T., Weisgraber, K.H., Zeevi, M.I., Ben‑Artzi, H., Levanon, A.Z.,
Rall, S.C., Innerarity, T.L., Hui, D.Y., Taylor, J.M., Kanner,
D., Yavin, Z., Amit, B., Aviv, H., Gorecki, M., and Mahley, R.W.
(1986) Human apolipoprotein E expression in Escherichia coli:
Structural and functional identity of the bacterially produced protein
with apoE. Proc. Natl. Acad. Sci. USA 82, 8696‑8700.
21.
Innerarity, T.L., Hui, D.Y., Bersot, T.P., and Mahley, R.W.
(1986) Type III hyperlipoproteinemia: A focus on lipoprotein
receptor‑apolipoprotein E2 interactions. In Proceedings of
Symposium on Lipoprotein Deficiency Syndromes (Angel, A., ed.),
Plenum Press, NY. pp. 273‑288.
22.
Mahley, R.W., Innerarity, T.L., Hui, D.Y., Rall, S.C., and
Weisgraber, K.H. (1986) Regulation of cholesterol metabolism by
hepatic lipoprotein receptors: Ligand receptor interaction. In
Atherosclerosis VII. (Nestel, P.J., ed.), Amsterdam, Elsevier
Science Publishers, pp. 119‑123.
23.
Hui, D.Y., Innerarity, T.L., and Mahley, R.W. (1986) Isolation
and characterization of the apolipoprotein E receptor. In
Atherosclerosis VII. (Nestel, P.J., ed.), pp. 329‑333.
24.
Mahley, R.W., Innerarity, T.L., Weisgraber, K.H., Rall, S.C., Hui,
D.Y., Lalazar, A., Boyles, J.K., Taylor, J.M., and Levy‑Wilson, B.
(1986) Cellular and molecular biology of lipoprotein metabolism.
Cold
Spring Harbor Symposia on Quant. Biol. Vol. LI, 821‑828.
25.
Hui, D.Y., Brecht, W., Hall, E.A., Friedman, G., Innerarity,
T.L., and Mahley, R.W. (1986) Isolation and characterization of the
apolipoprotein E receptor from canine and human liver. J. Biol.
Chem. 261, 4256-4267
26.
Pitas, R.E., Boyles, J.K., Lee, S.H., Hui, D.Y., and Weisgraber,
K.H. (1987) Lipoproteins and their receptors in the central nervous
system: Characterization of the lipoproteins in cerebrospinal fluid
and identification of apolipoprotein B,E (LDL) receptors in the
brain. J. Biol. Chem. 262, 14352‑14360.
27.
Friedman, G., Wernette‑Hammond, M.E., Hui, D.Y., Mahley, R.W.,
and Innerarity, T.L. (1987) Characterization of lipoprotein receptors
on rat Fu5AH hepatoma cells. J. Lipid Res. 28, 1482‑1494.
28.
Beisiegel, U., Weber, W., Haringa, J.R., Ihcke, G., Hui, D.Y.,
Wernette‑Hammond, M.E., Turck, C.W., Innerarity, T.L., and Mahley, R.W.
(1988) Apolipoprotein E binding proteins isolated from dog and human
liver. Arteriosclerosis 8, 288‑297.
29.
Mahley, R.W., Hui, D.Y., Innerarity, T.L., and Beisiegel, U.
(1989) Chylomicron remnant metabolism: Role of hepatic lipoprotein
receptors in mediating uptake. Arteriosclerosis 9, I14‑I18.
30.
Boyles, J.K., Zoellner, C.D., Anderson, L.J., Kosik, L.M., Pitas, R.E.,
Weisgraber, K.H., Hui, D.Y., Mahley, R.W., Gebicke‑Haerter, P.J.,
Ignatius, M.J.,and Shooter, E.M. (1989) A role for apolipoproteins E,
apolipoprotein A‑I, and low density lipoprotein receptors in
cholesterol transport during regeneration and remyelination of the rat
sciatic nerve. J. Clin. Invest. 83, 1015‑1031.
31.
Camulli, E.A., Linke, M.J., Brockman, H.L., and Hui, D.Y.
(1989) Identity of a cytosolic neutral cholesterol esterase in rat
liver with the pancreatic bile salt stimulated cholesterol
esterase. Biochim. Biophys. Acta 1005, 177‑182.
32.
Kissel, J.A., Fontaine, R.N., Turck, C., Brockman, H.L., and Hui,
D.Y. (1989) Molecular cloning and expression of the rat pancreatic
cholesterol esterase cDNA. Biochim. Biophys. Acta 1006,
227‑236.
33.
Yamashita, S., Hui, D.Y., Sprecher, D.L., Matsuzawa, Y., Sakai,
N., Tarui, S., Kaplan, D., Wetterau, J.R., and Harmony, J.A.K. (1990)
Total deficiency of plasma cholesteryl ester transfer protein in
subjects homozygous and heterozygous for the intron 14 splicing
defect. Biochem. Biophys. Res. Commun. 170, 1346‑1351.
34.
Yamashita, S., Sprecher, D.L., Sakai, N., Matsuzawa, Y., Tarui, S.,
and Hui, D.Y. (1990) Accumulation of apolipoprotein E‑rich high
density lipoproteins in hyperalphalipoproteinemic human subjects with
plasma cholesteryl ester transfer protein deficiency. J. Clin.
Invest. 86, 688‑695.
35.
DiPersio, L.P., Fontaine, R.N., and Hui, D.Y. (1990)
Identification of the active site serine in pancreatic cholesterol
esterase by chemical modification and site-specific mutagenesis.
J. Biol. Chem. 265, 16801‑16806
36.
Huang, Y., and Hui, D.Y. (1990) Metabolic fate of pancreas
derived cholesterol esterase in intestine: An in vitro study using
Caco‑2 cells. J. Lipid Res. 31, 2029‑2037
37.
Hui, D.Y., and Kissel, J.A. (1990) Sequence identity between
human pancreatic cholesterol esterase and bile salt‑stimulated milk
lipase. FEBS Letters 276, 131‑134.
38.
DiPersio, L.P., Fontaine, R.N., and Hui, D.Y. (1991) Site
specific mutagenesis of an essential histidine residue in pancreatic
cholesterol esterase.
J. Biol.
Chem.
266, 4033‑4036
39.
Huang, Y., and Hui, D.Y. (1991) Cholesterol esterase
biosynthesis in rat pancreatic AR42J cells: Post-transcriptional
activation by gastric hormones.
J. Biol.
Chem.
266, 6720-6725
40.
Yamashita, S., Hui, D.Y., Wetterau, J.R., Sprecher, D.L.,
Harmony, J.A.K., Sakai, N., Matsuzawa, Y., and Tarui, S. (1991)
Characterization of plasma lipoproteins in patients heterozygous for
human plasma cholesteryl ester transfer protein (CETP) deficiency:
Plasma CETP regulates high density lipoprotein concentration and
composition. Metabolism 40, 756-763
41.
Fontaine, R.N., Carter, C.P., and Hui, D.Y. (1991) Structure of
the rat cholesterol esterase gene. Biochemistry
30, 7008-7014
42.
DiPersio, L.P., Kissel, J.A., and Hui, D.Y. (1992) Expression
of sialylated and nonsialylated forms of cholesterol esterase in
Baculovirus-infected Sf9 cells.
Protein
Expression and Purification 3,
114-120
43.Hui, D.Y.,
Hayakawa, K., and Oizumi, J. (1993) Lipoamidase activity in normal
and mutagenized cholesterol esterase (bile salt stimulated lipase)
Biochemical J.
291, 65-69
44.
DiPersio, L.P., and Hui, D.Y. (1993) Aspartic acid-320 is
necessary for optimal activity of rat cholesterol esterase.
J. Biol. Chem. 268, 300-304
45.
Warden, C.H., Davis, R.C., Yoon, M.Y., Hui, D.Y., Svenson, K.,
Xia, Y.R., He, K.Y., and Lusis, A.J. (1993) Chromosomal organization
of lipolytic enzymes in the mouse: pancreatic lipase, colipase,
hormone sensitive lipase, hepatic lipase and carboxyl ester
lipase. J. Lipid Res. 34, 1451-1455
46.
Brodt-Eppley, J., and Hui, D.Y. (1994) Dietary regulation of
cholesterol esterase mRNA level in rat pancreas. J. Lipid Res.
35, 27-35
47.
Huang, Y., and Hui, D.Y. (1994) Synergistic effects of bombesin
and cholecystokinin on cholesterol esterase biosynthesis and secretion
by AR42J cells. Arch. Biochem. Biophys. 310, 54-59
48.
DiPersio, L.P., Carter, C.P., and Hui, D.Y. (1994) Exon 11 of
the rat cholesterol esterase gene encodes domains important for
intracellular processing and bile salt-modulated activity of the
protein. Biochemistry 33, 3442-3448
49.
Huang, Y., and Hui, D.Y. (1994) Increased cholesterol esterase
level by cholesterol loading of rat pancreatoma cells.
Biochim. Biophys. Acta 1214, 317-322
50.
Brodt-Eppley, J., and Hui, D.Y. (1995) Calcium mobilization and
protein kinase C activation are required for cholecystokinin
stimulation of pancreatic cholesterol esterase secretion.
Biochemical J. 306, 605-608
51.
Myers-Payne, S.C., Hui, D.Y., Brockman, H.L., and Schroeder, F.
(1995) Cholesterol esterase: A cholesterol transfer protein.
Biochemistry 34, 3942-3947
52.
Brodt-Eppley, J., White, P., Jenkins, S., and Hui, D.Y. (1995)
Plasma cholesterol esterase level is a determinant for an atherogenic
lipoprotein profile in normolipidemic human subjects. Biochim.
Biophys. Acta 1272, 69-72
53.
Howles, P.N., Carter, C.P., and Hui, D.Y. (1996) Dietary free
and esterified cholesterol absorption in cholesterol esterase (bile
salt-stimulated lipase) gene-targeted mice.
J. Biol.
Chem. 271,
7196-7202
54.
Li, F., Huang, Y., and Hui, D.Y. (1996) Bile salt stimulated
cholesterol esterase increases uptake of high density
lipoprotein-associated cholesteryl esters by HepG2 cells.
Biochemistry 35, 6657-6663
55.
Hui, D.Y. (1996) Molecular Biology of Cholesteryl ester
hydrolases in mammalian tissues. Biochim. Biophys. Acta 1303,
1-14
56.
Feaster, S.R., Lee, K., Baker, N., Hui, D.Y., and Quinn, D.M.
(1996) Molecular recognition by cholesterol esterase of active site
ligands: Structure-reactivity effects for inhibition by aryl
carbamates and subsequent carbamylenzyme turnover.
Biochemistry
35, 16723-16734
57.
Carter, C.P., Howles, P.N., and Hui, D.Y. (1997) Genetic
Variation in cholesterol absorption efficiency among inbred strains of
mice. J Nutrition 127, 1344-1348
58.
Hornick, C.A., Hui, D.Y., and DeLamatre, J.G. (1997) A role for
retrosomes in intracellular cholesterol transport from endosomes to
the plasma membrane.
Am. J.
Physiol.
273, C1075-C1081
59.
Hui, D.Y. (1997) Use of gene knockout mice to establish lipase
function.
Methods
in Enzymology
286, 67-80
60.
Li, F., and Hui, D.Y. (1997) Modified low density lipoprotein
enhances cholesterol esterase secretion by human monocytes-macrophages.
Species specific difference in macrophage cholesteryl ester hydrolase.
J. Biol. Chem. 272, 28666-28671
61.
Li, F., and Hui, D.Y. (1998) Synthesis and secretion of the
pancreatic-type carboxyl ester lipase by human endothelial cells.
Biochemical Journal 329, 675-679
62.
Qin, X., Swertfeger, D.K., Zheng, S., Hui, D.Y., and Tso, P.
(1998) Apolipoprotein A-IV: a potent endogenous inhibitor of lipid
oxidation. Am. J. Physiology. 274, H1836-H1840
63.
Ishigami, M., Swertfeger, D.K., Granholm, N.A., and Hui, D.Y.
(1998) Apolipoprotein E inhibits platelet-derived growth
factor-induced vascular muscle cell migration and proliferation by
suppressing signal transduction and preventing cell entry to G1
phase.
J. Biol.
Chem.
273, 20156-20161
64.
Hui, D.Y. (1998) Utility and importance of gene knockout
animals for nutritional and metabolic research. J. Nutrition
128, 2052-2057
65.
Young, S.C., and Hui, D.Y. (1999) Pancreatic lipase-colipase
mediated triglyceride hydrolysis is required for cholesterol transport
from lipid emulsions to intestinal cells. Biochem. J. 339,
615-620
66.
Howles, P.N., Stemmerman, G.N., Fenoglio-Preiser, C.M., and Hui,
D.Y. (1999) Cholesterol ester lipase activity in milk prevents
fat-derived intestinal injury in neonatal mice. Am. J. Physiology
277, G653-G661
67.
Richmond, B.L., and Hui, D.Y. (2000) Molecular structure and
tissue-specific expression of the mouse pancreatic phospholipase A2
gene. Gene244, 65-72
68.
Ishigami, M., Swertfeger, D.K., Hui, M.S., Granholm, N.A., and Hui,
D.Y. (2000) Apolipoprotein E inhibition of vascular smooth muscle
cell proliferation but not the inhibition of migration is mediated
through activation of inducible nitric oxide synthase.
Arterioscler. Thromb. Vasc. Biol.20, 1020-1026
69.
Howles, P.N., and Hui, D.Y. (2000) Cholesterol Estease. In:
Intestinal Lipid Metabolism (Mansbach, C., Tso, P., and Kuksis,
A., eds), Kluwer Academic/Plenum Publishers. Pp. 119-134.
70.
Liang, Y., Medhekar, R., Brockman, H.L., Quinn, D.M., and Hui, D.Y.
(2000) Importance of arginines 63 and 423 in modulating the bile
salt-dependent and bile salt-independent hydrolytic activities of rat
carboxyl ester lipase. J. Biol. Chem. 275,
24040-24046.
71.
Keelan, M., Hui, D.Y., Wild, G., Clandinin, M.T., and Thomson,
A.B.R. (2000) Variability of the intestinal uptake of lipids is
genetically determined in mice. Lipids35, 833-837.
72.Kuhel, D.G., Zheng, S., Tso, P., and Hui, D.Y. (2000)
Adenovirus mediated gene transfer for the ectopic expression of human
pancreatic lipase in rat bile: Implications for gene therapy of fat
malabsorption in pancreatic insufficiency.
Am. J. Physiology 279, G1031-G1036.
73.
Bridges, J.P., Davis, H.W., Damodarasamy, M., Kuroki, Y., Howles, G.,
Hui, D.Y., McCormack, F.X. (2000) Pulmonary surfactant proteins
A and D are potent endogenous inhibitors of lipid peroxidation and
oxidative cellular injury. J. Biol. Chem. 275,
38848-38855.
74.
Zhu, B., Kuhel, D.G., Witte, D., and Hui, D.Y. (2000)
Apolipoprotein E inhibits neointimal hyperplasia after arterial injury
in mice. Am. J. Pathology 157, 1839-1848.
75.
Swertfeger, D. K., and Hui, D.Y. (2001) Apolipoprotein E: A
cholesterol transport protein with lipid transport independent cell
signaling properties. Frontiers in Bioscience6,
D526-535.
76.
Richmond, B.L., Boileau, A., Zheng, S., Granholm, N.A., Tso, P., and
Hui, D.Y. (2001) Compensatory phospholipid digestion is
required for normal cholesterol and phospholipid absorption in
pancreatic phospholipase A2 gene-targeted mice.
Gastroenterology120, 1193-1202.
77.Du, H., Heur, M., Duanmu, M., Grabowski, G. A., Hui, D. Y.,
Witte, D.P., and Misra, J. (2001) Lysosomal acid lipase deficient
mice: depletion of white and brown fat, severe hepatosplenomegaly,
and shortened life span. J. Lipid Res.42, 489-500.
78.Cai, S. F., Kirby, R. J., Howles, P.N., and Hui, D. Y.
(2001) Differentiation-dependent expression and localization of the
Class B Type I scavenger receptor in intestine.
J. Lipid
Res.42, 902-909.
79.Swertfeger, D.K., and Hui, D.Y. (2001) Apolipoprotein E
receptor binding versus heparan sulfate proteoglycan binding in its
regulation of smooth muscle cell migration and proliferation. J.
Biol. Chem. 276, 25043-25048.
80.Zhu, B., Zhao, G., Witte, D.P., Hui, D.Y., and Fagin,
J.A. (2001) Targeted overexpression of IGF-1 in smooth muscle cells of
transgenic mice enhances neointimal formation through increased
proliferation and cell migration after intraarterial injury.
Endocrinology142, 3598-3606.
81.Riddle, T.A., Kuhel, D.G., Woollett, L.A., Fichtenbaum, C., and
Hui, D.Y. (2001) HIV protease inhibitor induces fatty acid and
sterol biosynthesis in liver and adipose tissues due to the
accumulation of activated sterol regulated element binding proteins in
the nucleus. J. Biol. Chem. 276, 37514-37519.
82.Kirby, R.J., Zheng, S., Tso, P., Howles, P.N., and Hui, D.Y.
(2002) Bile salt-stimulated carboxyl ester lipase influences
chylomicron assembly and secretion in intestine: A process mediated
via ceramide hydrolysis. J. Biol. Chem. 277, 4104-4109.
83.
Swertfeger, D.K., Bu, G., and Hui, D.Y. (2002) Low density
lipoprotein receptor-related protein mediates apolipoprotein E
inhibition of smooth muscle cell migration. J. Biol. Chem.
277, 4141-4146.
84.Zhu, B., Reardon, C.A., Getz, G.S., and Hui, D.Y. (2002)
Both apolipoprotein E- and T and B lymphocyte-deficiency contribute to
exacerbated neointimal hyperplasia after vascular injury in mice.
Arterioscler. Thromb. Vasc. Biol. 22, 450-455.
85.Yao, L., Heubi, J. E., Buckley, D.D., Fierra, H., Setchell,
K.D.R., Granholm, N.A., Tso, P., Hui, D.Y., and Woollett, L.A.
(2002) Separation of micelles and vesicles within lumenal aspirates
from healthy humans: Solubilization of cholesterol after a meal.
J. Lipid Res.43, 654-660.
86.Kuhel, D.G., Zhu, B., Witte, D. P. and Hui, D.Y. (2002)
Distinction in Genetic Determinants for injury-induced neointimal
hyperplasia and diet-induced atherosclerosis in inbred mice.
Arterioscler. Thromb. Vasc. Biol.22, 955-960.
87.Riddle, T. M., Schildmeyer, N., Phan, C., Fichtenbaum, C. J.,
and Hui, D. Y. (2002) The HIV protease inhibitor ritonavir
increases lipoprotein production and has no effect on lipoprotein
clearance in mice. J. Lipid Res. 43, 1458-1463.
88.Panagotopulos, S. E., Witing, S. R., Morace, E. M., Hui, D.
Y., Maiorano, J. N., and Davidson, W. S. (2002) The role of
apolipoprotein A-I bellix in apolipoprotein-mediated cholesterol
efflux via ATP-binding cassette transporter (ABCA1). J. Biol.
Chem.277, 39477-39484.
89.Huggins, K. W., Boileau, A. C., and Hui, D. Y. (2002)
Protection against diet-induced obesity and obesity-related insulin
resistance in Group 1B Phospholipase A2 deficient mice.
Am. J. Physiol. 283, E994-E1001.
90.Zeleny, M., Swertfeger, D. K., Weisgraber, K. H., and Hui,
D. Y. (2002) Distinct apolipoprotein E isoform preference for
inhibition of smooth muscle cell migration and proliferation.
Biochemistry41, 11820-11823.
91.Hui, D.Y.
and
Howles, P.N. (2002) Carboxyl ester lipase: structure-function
relationship and physiological role in lipoprotein metabolism and
atherosclerosis. J. Lipid Res. 43, 2017-2030.
92.Hui, D.
Y. (2003)
Effects of HIV protease inhibitor therapy on lipid metabolism Prog.
Lipid Res. 42, 81-92.
93.Hui,D. Y. (2003) HIV protease inhibitors and atherosclerosis.
J. Clin. Invest. 111, 317-318.
94.Riddle, T.M., Fichtenbaum, C.J., and Hui, D.Y. (2003)
Leptin replacement therapy but not dietary polyunsaturated fatty acid
ameliorates HIV protease inhibitor-induced dyslipidemia and
lipodystrophy in mice. J. Acquir. Immune Defic. Syndr. 33,
564-570.
95.Zhu, Y. and Hui, D.Y. (2003) Apolipoprotein E binding to
low density lipoprotein receptor related protein-1 inhibits cell
migration via activation of cyclic 3’,5’-adenosine monophosphate
dependent protein kinase A. J. Biol. Chem.278,
36257-36263.
96.Huggins, K.W., Camarota, L.M., Howles, P.N. and Hui, D.Y.
(2003) Pancreatic triglyceride lipase deficiency minimally affects
dietary fat absorption but dramatically decreases dietary cholesterol
absorption in mice. J. Biol. Chem.278, 42899-42905.
97.Hui, D.
Y. (2004)
Cholesterol absorption. In: Encyclopedia of Gastroenterology
(Johnson, L., ed.), Elsevier Press, New York, pp. 343-350.
98.Kirby, R.J., Howles, P.N., and Hui, D.Y. (2004) Rate of
gastric emptying influences dietary cholesterol absorption efficiency
in selected inbred strains of mice. J. Lipid Res.45,
89-98.
99.Hui, D.
Y.
and Basford, J. E. (2004) Distinct signaling mechanisms for apoE
inhibition of cell migration and proliferation. Neurobiol. Aging
(in the press)
100.Herz, J. and Hui, D.Y. (2004) Lipoprotein receptors in
the vascular wall. Curr. Opin. Lipidol. (in the press)
101.Moore, Z.W.Q., Zhu, B., Kuhel, D.G., and Hui, D.Y.
(2004) Apolipoprotein E is locally expressed and recruited from
circulation to the vessel wall to modulate smooth muscle cell response
to endothelial denudation. Am. J. Pathol.2004 Jun; 164(6):2109-16